These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35185875)

  • 1. HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity.
    Hovhannisyan A; Madelian V; Avagyan S; Nazaretyan M; Hyussyan A; Sirunyan A; Arakelyan R; Manukyan Z; Yepiskoposyan L; Mayilyan KR; Jordan F
    Front Immunol; 2022; 13():769900. PubMed ID: 35185875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients.
    Iturrieta-Zuazo I; Rita CG; García-Soidán A; de Malet Pintos-Fonseca A; Alonso-Alarcón N; Pariente-Rodríguez R; Tejeda-Velarde A; Serrano-Villar S; Castañer-Alabau JL; Nieto-Gañán I
    Clin Immunol; 2020 Oct; 219():108572. PubMed ID: 32810602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.
    Khor SS; Omae Y; Nishida N; Sugiyama M; Kinoshita N; Suzuki T; Suzuki M; Suzuki S; Izumi S; Hojo M; Ohmagari N; Mizokami M; Tokunaga K
    Front Immunol; 2021; 12():658570. PubMed ID: 33968060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.
    Littera R; Campagna M; Deidda S; Angioni G; Cipri S; Melis M; Firinu D; Santus S; Lai A; Porcella R; Lai S; Rassu S; Scioscia R; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Serra M; Ragatzu P; Carta MG; Del Giacco S; Restivo A; Deidda S; Orrù S; Palimodde A; Perra R; Orrù G; Conti M; Balestrieri C; Serra G; Onali S; Marongiu F; Perra A; Chessa L
    Front Immunol; 2020; 11():605688. PubMed ID: 33343579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.
    Nguyen A; David JK; Maden SK; Wood MA; Weeder BR; Nellore A; Thompson RF
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32303592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral-Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People.
    Basir HRG; Majzoobi MM; Ebrahimi S; Noroozbeygi M; Hashemi SH; Keramat F; Mamani M; Eini P; Alizadeh S; Solgi G; Di D
    Front Immunol; 2022; 13():891816. PubMed ID: 35911710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19.
    Shkurnikov M; Nersisyan S; Jankevic T; Galatenko A; Gordeev I; Vechorko V; Tonevitsky A
    Front Immunol; 2021; 12():641900. PubMed ID: 33732261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between human leukocyte antigen alleles and COVID-19 disease severity.
    Hajeer A; Jawdat D; Massadeh S; Aljawini N; Abedalthagafi MS; Arabi YM; Alaamery M
    J Infect Public Health; 2024 Sep; 17(9):102498. PubMed ID: 39173558
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Naidoo L; Arumugam T; Ramsuran V
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19.
    Fischer JC; Schmidt AG; Bölke E; Uhrberg M; Keitel V; Feldt T; Jensen B; Häussinger D; Adams O; Schneider EM; Balz V; Enczmann J; Rox J; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Lichtenberg A; Freise NF; Lutterbeck M; Rezazadeh A; Budach W; Matuschek C
    Eur J Med Res; 2021 Sep; 26(1):107. PubMed ID: 34530915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.
    Alnaqbi H; Tay GK; Jelinek HF; Francis A; Alefishat E; El Haj Chehadeh S; Tahir Saeed A; Hussein M; Laila Salameh ; Mahboub BH; Uddin M; Alkaabi N; Alsafar HS;
    Hum Immunol; 2022 Jan; 83(1):1-9. PubMed ID: 34462158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the HLA genotype and the severity of COVID-19 infection among South Asians.
    Naemi FMA; Al-Adwani S; Al-Khatabi H; Al-Nazawi A
    J Med Virol; 2021 Jul; 93(7):4430-4437. PubMed ID: 33830530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19.
    Castro-Santos P; Rojas-Martinez A; Riancho JA; Lapunzina P; Flores C; Carracedo Á; Díaz-Peña R;
    HLA; 2023 Dec; 102(6):731-739. PubMed ID: 37528566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.
    Ben Shachar S; Barda N; Manor S; Israeli S; Dagan N; Carmi S; Balicer R; Zisser B; Louzoun Y
    J Clin Immunol; 2021 Aug; 41(6):1154-1161. PubMed ID: 34050837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ancestral origins are associated with SARS-CoV-2 susceptibility and protection in a Florida patient population.
    Shen Y; Khatri B; Rananaware S; Li D; Ostrov DA; Jain PK; Lessard CJ; Nguyen CQ
    PLoS One; 2023; 18(1):e0276700. PubMed ID: 36649279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA Allele Frequencies and Association with Severity of COVID-19 Infection in Northern Italian Patients.
    Guerini FR; Bolognesi E; Lax A; Bianchi LNC; Caronni A; Zanzottera M; Agliardi C; Albergoni MP; Banfi PI; Navarro J; Clerici M
    Cells; 2022 May; 11(11):. PubMed ID: 35681490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality.
    Sakuraba A; Haider H; Sato T
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33233780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease.
    Hosseini E; Minagar A; Ghasemzadeh M; Arabkhazaeli A; Ghasemzadeh A
    Hum Immunol; 2023 Apr; 84(4):263-271. PubMed ID: 36822912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.